BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Ponziani FR, Mangiola F, Binda C, Zocco MA, Siciliano M, Grieco A, Rapaccini GL, Pompili M, Gasbarrini A. Future of liver disease in the era of direct acting antivirals for the treatment of hepatitis C. World J Hepatol 2017; 9(7): 352-367 [PMID: 28321272 DOI: 10.4254/wjh.v9.i7.352]
URL: https://www.wjgnet.com/1948-5182/full/v9/i7/352.htm
Number Citing Articles
1
U. Fedeli. Increasing mortality associated with the more recent epidemic wave of hepatitis C virus infection in Northern ItalyJournal of Viral Hepatitis 2018; 25(8): 996 doi: 10.1111/jvh.12893
2
Valentina Cossiga, Marco Sanduzzi-Zamparelli, Victor Sapena, Maria Guarino, Marcello Dallio, Emanuele Torrisi, Luca Pignata, Alessandro Federico, Federico Salomone, Filomena Morisco. Beneficial Effects of Silybin Treatment After Viral Eradication in Patients With HCV-Related Advanced Chronic Liver Disease: A Pilot StudyFrontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.824879
3
Antoni Sicras-Mainar, Ruth Navarro-Artieda, Marc Sáez-Zafra. Comorbidity, concomitant medication, use of resources and healthcare costs associated with chronic hepatitis C virus carriers in SpainGastroenterología y Hepatología (English Edition) 2018; 41(4): 234 doi: 10.1016/j.gastre.2018.04.015
4
Reham M. Dawood, Mai Abd el-Meguid, Marwa K. Ibrahim, Noha G. Bader El Din, Ahmed Barakat, Khaled El-Wakeel, Mohamed Darwish Ahmed Abd Alla, George Y. Wu, Mostafa K. El Awady. Dysregulation of fibrosis related genes in HCV induced liver diseaseGene 2018; 664: 58 doi: 10.1016/j.gene.2018.04.032
5
Hisham A. Ismail, Doaa Ebrahim, Mohamed A. El-Assal, Mai Abozeid, Eman Abdelsameea. Predictive value of hepcidin in patients with chronic hepatitis C infection among EgyptiansEgyptian Liver Journal 2018; 8(1): 12 doi: 10.1097/01.ELX.0000530863.06773.be
6
Viola Knop, Stefan Mauss, Tobias Goeser, Andreas Geier, Tim Zimmermann, Kerstin Herzer, Nils Postel, Mireen Friedrich‐Rust, Wolf Peter Hofmann, Katrin Ende, Anita Pathil, Tilman Bauer, Stefan Zeuzem, Thomas Berg, Markus Cornberg, Norbert Börner, Marc Ringelhan, Hartwig Klinker, Thorsten Schlenker, Thomas Lutz, Hauke Heinzow, Rainer Günther, Heiner Busch, Axel Baumgarten, Peter Buggisch, Martin Roessle, Dietrich Hüppe, Michael P. Manns, Claus Niederau, Christoph Sarrazin, Peter Schirmacher, Karl‐Georg Simon, Heiner Wedemeyer. Dynamics of liver stiffness by transient elastography in patients with chronic hepatitis C virus infection receiving direct‐acting antiviral therapy—Results from the German Hepatitis C‐RegistryJournal of Viral Hepatitis 2020; 27(7): 690 doi: 10.1111/jvh.13280
7
Francesca Romana Ponziani, Francesco Santopaolo, Massimo Siciliano, Antonio Giulio De Belvis, Annalisa Tortora, Vincenzina Mora, Caterina Fanali, Alisha Morsella, Fulvio Balducci, Giuseppe Vetrugno, Maria Elena D’Alfonso, Andrea Cambieri, Roberto Cauda, Rocco Bellantone, Maurizio Sanguinetti, Maurizio Pompili, Antonio Gasbarrini. Missed linkage to care for patients who screened positive for Hepatitis C in a tertiary care centre: Results of the Telepass projectJournal of Viral Hepatitis 2021; 28(4): 651 doi: 10.1111/jvh.13465
8
Daniel Sepulveda-Crespo, Salvador Resino, Isidoro Martinez. Hepatitis C virus vaccine design: focus on the humoral immune responseJournal of Biomedical Science 2020; 27(1) doi: 10.1186/s12929-020-00669-4
9
A. Erman, A. Sathya, A. Nam, J. M. Bielecki, J. J. Feld, H‐H. Thein, W. W. L. Wong, P. Grootendorst, M. D. Krahn. Estimating chronic hepatitis C prognosis using transient elastography‐based liver stiffness: A systematic review and meta‐analysisJournal of Viral Hepatitis 2018; 25(5): 502 doi: 10.1111/jvh.12846
10
Aparna Vasanthakumar, Justin W. Davis, Manal Abunimeh, Jonas Söderholm, Jiuhong Zha, Emily O. Dumas, Daniel E. Cohen, Jeffrey F. Waring, Martin Lagging, Tatsuo Kanda. Reduced ITPase activity and favorable IL28B genetic variant protect against ribavirin-induced anemia in interferon-free regimensPLOS ONE 2018; 13(5): e0198296 doi: 10.1371/journal.pone.0198296
11
Kellie Young, Benny Liu, Taft Bhuket, Robert J. Wong. Lower Likelihood of Post-transplant Graft Failure, Death, and Retransplantation in the Era of Direct-Acting AntiviralsJournal of Clinical and Experimental Hepatology 2020; 10(6): 581 doi: 10.1016/j.jceh.2020.02.003
12
Camelia A. Abdel Malak, Tawfeek H. Abelhafez, Ashraf A. Tabll, Mohammad M. Mashaly, Reem El Shenawy, Yasmine S. El-Abd, Maysa H. Shaker, Mostafa K. El-Awady. Neutralizing activity and safety of human monoclonal antibodies against hepatitis C virusHuman Antibodies 2018; 26(3): 127 doi: 10.3233/HAB-170330
13
Masashi Mizokami, Lauren J. Liu, Naoto Fujiyama, Marcus Littman, Jason Yuan, Tomoko Sekiya, Charlotte Hedskog, Leslie J. Ng. Real‐world safety and effectiveness of ledipasvir/sofosbuvir for the treatment of chronic hepatitis C virus genotype 1 in JapanJournal of Viral Hepatitis 2021; 28(1): 129 doi: 10.1111/jvh.13395
14
Kellie Young, Benny Liu, Taft Bhuket, Robert G. Gish, Robert J. Wong. Improved liver transplant waitlist mortality and lower risk of disease progression among chronic hepatitis C patients awaiting liver transplantation after the introduction of direct-acting antiviral therapies in the United StatesJournal of Viral Hepatitis 2019; 26(3): 350 doi: 10.1111/jvh.13039
15
T. Medeiros, N. F. Rosário, G. N. Saraiva, T. G. Andrade, A. A. Silva, J. R. Almeida. Renal safety after one year of sofosbuvir‐based therapy for chronic hepatitis C: A Brazilian “real‐life” studyJournal of Clinical Pharmacy and Therapeutics 2018; 43(5): 707 doi: 10.1111/jcpt.12697
16
Francesca Romana Ponziani, Luca Miele, Annalisa Tortora, Manuele Furnari, Giorgia Bodini, Maurizio Pompili, Antonio Gasbarrini, Edoardo Giovanni Giannini. Treatment of early stage chronic hepatitis C virus infectionExpert Review of Clinical Pharmacology 2018; 11(5): 519 doi: 10.1080/17512433.2018.1447923
17
Maliha Naseer, Harleen Chela, Alhareth AlJuboori. Viral Hepatitis: Chronic Hepatitis C2019; : 25 doi: 10.1007/978-3-030-03757-4_2
18
Daniel Sepulveda-Crespo, Salvador Resino, Isidoro Martinez. Innate Immune Response against Hepatitis C Virus: Targets for Vaccine AdjuvantsVaccines 2020; 8(2): 313 doi: 10.3390/vaccines8020313
19
Melisa Dirchwolf, Sebastián Marciano, Diego H. Giunta, Maria L. Posadas-Martínez, Scott W. Biggins, Andrés E. Ruf. Trends in liver transplantation for hepatitis C in a country with reduced access to direct-acting antiviral agentsClinical Transplantation 2018; 32(4): e13230 doi: 10.1111/ctr.13230
20
Karoly Toth, Ann E. Tollefson, Jacqueline F. Spencer, Baoling Ying, William S.M. Wold. Combination therapy with brincidofovir and valganciclovir against species C adenovirus infection in the immunosuppressed Syrian hamster model allows for substantial reduction of dose for both compoundsAntiviral Research 2017; 146: 121 doi: 10.1016/j.antiviral.2017.08.002
21
Alejandra Pérez-García, Aitziber Aguinaga, Ana Navascués, Jesús Castilla, Carmen Ezpeleta. Hepatitis C core antigen: Diagnosis and monitoring of patients infected with hepatitis C virusInternational Journal of Infectious Diseases 2019; 89: 131 doi: 10.1016/j.ijid.2019.09.022
22
Dan C. S. Im, Susheel Reddy, Claudia Hawkins, Shannon Galvin. Characteristics and Specialist Linkage to Care of Patients Diagnosed With Chronic Hepatitis C Across Different Settings in an Urban Academic Hospital: Implications for Improving Diagnosis and Linkage to CareFrontiers in Microbiology 2021; 12 doi: 10.3389/fmicb.2021.576357
23
David E. Bloom, Alexander Khoury, V. Srinivasan, Dario Ummarino. Estimating the net value of treating hepatitis C virus using sofosbuvir-velpatasvir in IndiaPLOS ONE 2021; 16(7): e0252764 doi: 10.1371/journal.pone.0252764
24
Paul Kubes, Craig Jenne. Immune Responses in the LiverAnnual Review of Immunology 2018; 36(1): 247 doi: 10.1146/annurev-immunol-051116-052415
25
Maria Janda, Kari A. Mergenhagen. The Effect of Psychosocial Factors on Success Rates of Hepatitis C TreatmentPsychosomatics 2017; 58(6): 624 doi: 10.1016/j.psym.2017.07.003
26
Gastón J. Piñeiro, Jordi Rovira, Fritz Diekmann, Nuria Esforzado. ReplyLiver Transplantation 2020; 26(6): 847 doi: 10.1002/lt.25761
27
Luciana D. Silva, Tatiana Bering, Gifone A. Rocha. The impact of nutrition on quality of life of patients with hepatitis CCurrent Opinion in Clinical Nutrition & Metabolic Care 2017; 20(5): 420 doi: 10.1097/MCO.0000000000000396
28
Léonie Petitclerc, Guillaume Gilbert, Bich N. Nguyen, An Tang. Liver Fibrosis Quantification by Magnetic Resonance ImagingTopics in Magnetic Resonance Imaging 2017; 26(6): 229 doi: 10.1097/RMR.0000000000000149
29
Fardad Ejtehadi, Paymun Farahvashi, Alireza Shamsaeefar, Ramin Niknam, Gholam Reza Sivandzadeh, Ladan Aminlari, Nasrin Motazedian, Kourosh Kazemi, Hamed Nikoupour, Saman Nikeghbalian, Hesameddin Eghlimi, Alireza Taghavi, Mohammadreza Fattahi, Kamran Bagheri Lankarani, Seyyed Ali Malek-Hosseini. Clinical Course and Outcome of Liver Transplantation in Patients with Hepatitis C in IranHepatitis Monthly 2021; 21(3) doi: 10.5812/hepatmon.108405
30
Valentina Pecoraro, Rita Banzi, Elisabetta Cariani, Johanna Chester, Erica Villa, Roberto D'Amico, Vittorio Bertele', Tommaso Trenti. New Direct-Acting Antivirals for the Treatment of Patients With Hepatitis C Virus Infection: A Systematic Review of Randomized Controlled TrialsJournal of Clinical and Experimental Hepatology 2019; 9(4): 522 doi: 10.1016/j.jceh.2018.07.004
31
Heba Omar, Mohamed Said, Rasha Eletreby, Mai Mehrez, Mohamed Bassam, Zeinab Abdellatif, Adel Hosny, Sherif Megawer, Mona El Amir, Ayman Yosry. Longitudinal assessment of hepatic fibrosis in responders to direct-acting antivirals for recurrent hepatitis C after liver transplantation using noninvasive methodsClinical Transplantation 2018; 32(8): e13334 doi: 10.1111/ctr.13334
32
Turabian Jose L. A Narrative Review of Natural History of Diseases and Continuity of Care in Family MedicineArchives of Community Medicine and Public Health 2017; : 041 doi: 10.17352/2455-5479.000023
33
Felice Nava, Alberto Chiesa, Giovanni Strepparola, Giuseppe Pennisi, Rossano Vitali, Lucia Trevisi, Alfio Lucchini. The earlier the better. The cost of health services in treating PWIDs with chronic hepatitis C: Results from a non-interventional studyMISSION 2020; (54) doi: 10.3280/mis54-2020oa10583
34
Maurizio Sessa, Francesca Futura Bernardi, Andrea Vitale, Beniamino Schiavone, Giulia Gritti, Annamaria Mascolo, Michele Bertini, Cristina Scavone, Liberata Sportiello, Francesco Rossi, Annalisa Capuano. Adverse drug reactions during hepatitis C treatment with direct-acting antivirals: The role of medication errors, their impact on treatment discontinuation and their preventability. New insights from the Campania Region (Italy) spontaneous reporting systeJournal of Clinical Pharmacy and Therapeutics 2018; 43(6): 867 doi: 10.1111/jcpt.12744
35
Antoni Sicras-Mainar, Ruth Navarro-Artieda, Marc Sáez-Zafra. Comorbilidad, medicación concomitante, uso de recursos y costes sanitarios asociados a los pacientes portadores del virus de la hepatitis C crónica en EspañaGastroenterología y Hepatología 2018; 41(4): 234 doi: 10.1016/j.gastrohep.2017.11.008
36
Chao He, Xiaojuan Liu, Wei Peng, Chuan Li, Tian-fu Wen. Evaluation the efficacy and safety of simultaneous splenectomy in liver transplantation patientsMedicine 2018; 97(10): e0087 doi: 10.1097/MD.0000000000010087
37
Caroline Schmidbauer, Michael Schwarz, Angelika Schütz, Raphael Schubert, Cornelia Schwanke, Enisa Gutic, Roxana Pirker, Tobias Lang, Thomas Reiberger, Hans Haltmayer, Michael Gschwantler, Giordano Madeddu. Directly observed therapy at opioid substitution facilities using sofosbuvir/velpatasvir results in excellent SVR12 rates in PWIDs at high risk for non-adherence to DAA therapyPLOS ONE 2021; 16(6): e0252274 doi: 10.1371/journal.pone.0252274